IN IT I AL REVI EW ENG I NEERI NG R EPORT PMN : 15 - 02 4 7 Focus Ready Draft 2/ 1 9/20 1 5 ENG I N EER : Jon \ DOH PV ( kg/yr) : 33 , 000 SUBMI TTER : H . B . Fu ll er Compan y

MSDS : Yes Labe l : No Gen Eqp t: Wear safety g l asses . 

### II Wear chemically res i stan t g l oves and long sleeved shi r t . // Use loca l exhau st vent il a ti on or oth er e n g i neer i ng con t r o l s to m in imi ze expos u re . Resp ir ator : Use a respirato r i f general room ve n til a t ion i s no t ava i l ab l e o r suffi c i en t to e lim inate symptoms . NIOSH approved air p u r i fying resp ir ator with o r gan i c vapo r car tr i dge . H

ea l t h Effects : E yes : Can cause i rr i t at i o n . 

### I Ski n : Can cause moderate ski n i r r i tat ion, de f at ti ng, and dermat it i s . Not l i kely to cause perman ent damage . May cause sensit i zat ion . // Inha l a t ion : Can cause moderat e resp i rat ory irr i ta ti on . May cause a l l e r g i c r esp i ra t ory r eaction . Other poss i ble symptoms i n c l ude : wheezi n g and cough i ng due t o pu l mo n ary edema ( fl u i d b u il d - u p in l ungs) . If produ ct i s heat ed or if a n ae r osol/mi s t i s ge n erated , a i rbo n e conce n tra ti ons may be reached t h at cause i r r i t at i on or o t h er adverse e f f ects . Inhalat i on o f h igh conce n t rat i o n s may res u l t in centr a l n ervou s system (CNS) effects such as d i zz i ness , weakness , f a t igue , nausea , headach e , a n d l ac k o f coordi n at i o n . //Ingestion : H armf ul i f swall owed . Ingest i on i s n ot an a n t i cipated rou te o f exposure . Irri tat ing t o mouth , t h roat , a n d stomach . 

### II Chr on i c E f f ec t s : May cau se t u mors based on tests with l aborat ory a n i mals . //Target Organs : Lungs , S k in . TLV/ PEL : Ethy l Acetat e (CASRN 14 1 - 78 - 6) 30 wt% 400 ppm TWA ACG I H Expos ure Limi ts Ethy l Acetat e (CASRN 1 4 1 - 78 - 6) 30 wt% 400 ppm TWA OS H A PEL Ethy l Acetat e (CASRN 1 4 1 - 78 - 6) 30 wt% 1400 mg/m3 TWA OSHA PEL Methylene Bisphe n y l Di isocyanate (MD I ) (CASRN 10 1 - 68 - 8) 5 wt% 0 . 005 ppm TWA ( li sted under Me t hy l ene b i sphenyl isocyanate (MD I )) ACG I H Expos u re Limi ts Methylene B i sph enyl D i isocyan ate (MD I ) (CAS RN 1 01 - 68 - 8) 5 wt% 0 . 02 ppm Ce il ing OSHA PEL Methylene Bisphe n y l Di isocyanate (MD I ) (CASRN 10 1 - 68 - 8) 5 wt% 0 . 2 mg/m3 Ce il ing OSHA PEL

### 2/ 1 0/20 1 5) : Re l ated Case c SAT In f o · Simil a r Case . Analogs : Migration to r : H yd PB T ra ti ng : P3 B 1T l PMN : Pl B l T l ; H yd Pd t : P 3B 1T l H

ea l th : 1 - 2 Dermal, I nha l a t ion Eco : 1 No releases to wate r

### OCCU PAT I ONAL EXPOSURE RAT I NG : 2 B NOTES & KEY ASSUMPTI ONS :

EXPOSURE - BAS ED R EVI EW : No

### IN IT I AL REVI E W ENG I NEERI NG REPORT PMN : 15 - 0247 Manufacturing Number o f Si t tion : 2 H. B . Ful l er Company Grand Rap i ds M I 49544 - 1 1 98 H. B . Ful l er Company Pilot F ac i l i t y St. Pau l MN 55 11 0 Days/yr : 3

ENV I RONMENTAL R ELEASES ESTIMATE SUMMARY

OCCUPAT I ONAL EXPOSURES ESTIMATE SUMMARYI n ha l a ti on : n eg li gib l e (VP < 0 . 00 1 torr )

Dermal : Expo s ure to Li q u id at 66 . 59% concentrati on H

igh End : > Po t en t ia l Dose Ra t e : 1 . 5E + 3 mg/day ove r 3 days/y r > Lifetime Ave r age Da il y Do s e : 1 . 0 E - 1 mg/day over 3 days/yr >Ave r age Dai l y Dose : 1 . 8E - 1 mg/day over 3 days/yr >Acu t e Pote n t i al Dose : 2 . 1 E+ 1 mg/day ove r 3 days/yr N

u mbe r o f wo r ke r s (a ll s i tes) with de r ma l expos ure : 6IN IT I AL REVI EW ENG I NEERI NG REPORT**P~ :**  2 Sonoco Eau Cla i re W I Plastic Packag i ng H i ckory NC Days/yr : 260

ENV I RONMENTAL R ELEASES ESTIMATE SUMMARY

OCCUPAT I ONAL EXPOSURES ESTIMATE SUMMARY

### I nha l a ti on : Expos ure to M i s t (non - vo l a t i l e) (C l ass I ) Low End o f Ra n ge : > Pote n t i a l D ose Rate : 4 . 0E - 1 mg/day over 2 5 0 days/yr > Life time Average Da i ly Dose : 2 . 2E - 3 mg/ kg - day over 2 5 0 days/y r >Ave r age Dai l y D ose : 3 . 9E - 3 mg/day over 250 days/yr >Acu t e Pote n t i al Dose : 5 . 7 E - 3 mg/day over 2 5 0 days/y r H

i g h End o f Ra n ge : > Pote n t i a l D ose Rate : 2 . 6E+O mg/day over 2 5 0 days/yr > Life time Average Da i ly Dose : 1 .5 E - 2 mg/ kg - day over 2 5 0 days/y r >Ave r age Dai l y D ose : 2 . 5E - 2 mg/day over 250 days/yr >Acu t e Pote n t i al Dose : 3 . 7 E - 2 mg/day over 2 5 0 days/y r N

u mbe r o f wo r ke r s (a ll s i tes) with i nh a l ation exposu r e : 6 NOTE : Th e respirator c l ass i s : I . Part icu l a t e ( in c l ud ing so l id or l iqu i d d r op l e t s) . INHALAT I O N M ONI TOR I NG D A

TA R EVIEW 1) U n certainty (est i mate based on mode l, o r data no t spec i f i c t o i ndu stry) : 2)a) Exposu r e l eve l > 1 mg/day? regulatory lim it, Yes O

R b) H azard Rati n g f or heal t h o f 2 or great er? 1 - 2 = > I nh a l at i o n Mo ni tor ing Dat a Des i red? N o D

ermal : Expos ure to Li q u id at 66 . 59% concentrati on H

igh End : > Po t en t ia l Dose Rat e : 1 .5 E+ 3 mg/day ove r 250 days/yr Yes No

> Lifetime Ave r age D a il y Dose : 8 . 4E+ O mg/day over 2 5 0 days/yr >Ave r age Dai l y D ose : 1 . 5E+1 mg/day over 250 days/yr >Acu t e Pote n t i al Dose : 2 . 1 E+ 1 mg/day over 2 5 0 days/y r N

u mbe r o f wo r ke r s (a ll s i tes) with de r ma l expos ure : 6